- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£222.1b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£143.18
7D
8.2%
1Y
40.0%
Gilead Sciences
Market Cap: US$153.8b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$127.88
7D
3.3%
1Y
15.6%
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,434.00
7D
-1.5%
1Y
-1.1%
Orion Oyj
Market Cap: €9.9b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€70.00
7D
3.9%
1Y
10.5%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥42.1b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥93.47
7D
10.0%
1Y
0.4%
Xiamen Amoytop Biotech
Market Cap: CN¥21.6b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥52.93
7D
-5.2%
1Y
-26.6%
PharmaResearch
Market Cap: ₩3.4t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩324,000.00
7D
10.2%
1Y
-33.3%